Home › Funds › Two Sigma Investments › PRME
Two Sigma Investments position in PRME
PRIME MEDICINE INC · Health Care
Latest position (Q2 2026)1.52M sh
Reported value held$5.63M
Portfolio Weight0.00%
First reportedQ3 2023
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 92.99K | $887.15K | New |
| Q4 2023 | 268.36K | $2.38M | Add |
| Q1 2024 | 508.08K | $3.56M | Add |
| Q2 2024 | 681.48K | $3.50M | Add |
| Q3 2024 | 318.57K | $1.23M | Reduce |
| Q4 2024 | 166.20K | $485.30K | Reduce |
| Q1 2025 | 258.77K | $514.95K | Add |
| Q2 2025 | 258.42K | $638.30K | Hold |
| Q3 2025 | 447.67K | $2.48M | Add |
| Q4 2025 | 1.63M | $5.65M | Add |
| Q1 2026 | 1.57M | $5.47M | Reduce |
| Q2 2026 | 1.52M | $5.63M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding PRME
- BlackRock Inc 9.60M sh · $35.43M · Q2 2026
- ARK Invest 8.35M sh · $30.81M · Q2 2026
- Vanguard Group 6.47M sh · $22.44M · Q4 2025
- Balyasny Asset Management 3.97M sh · $14.65M · Q2 2026
- Goldman Sachs Group 3.43M sh · $12.66M · Q2 2026
- Casdin Capital 3.17M sh · $11.69M · Q2 2026
- UBS Group AG 2.79M sh · $10.31M · Q2 2026
- Geode Capital Management 2.71M sh · $10.01M · Q2 2026
- Citadel Advisors 2.35M sh · $8.68M · Q2 2026
- Fidelity Management & Research (FMR) 1.76M sh · $6.50M · Q2 2026
- Farallon Capital Management 1.24M sh · $4.58M · Q2 2026